Physician profile
John S Marouk
NPI 1427099035
$3,554.13
in general payments reported to CMS, 2019-2025
11 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.27 · 2021: $41.97 · 2022: $2,861 · 2023: $439 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,564.82 | 2022 | |
| Intrinsic Therapeutics | $390.62 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic, INC. | $194.72 | 2022-2025 | Mazor X System |
| Zimvie INC. | $131.98 | 2023 | |
| Cerapedics INC. | $110.18 | 2022 | |
| Stryker Corporation | $34.16 | 2025 | Direct Inject |
| Davol INC. | $32.06 | 2022 | |
| Providence Medical Technology, INC. | $30.35 | 2025 | |
| Integra Lifesciences Corporation | $23.99 | 2021 | |
| Pfizer INC. | $23.27 | 2019 | |
| Amgen INC. | $17.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.